Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. N-(4-(2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl)phenyl)-2-benzothiazolamine
2. R 115866
3. R-115866
4. R115866
5. Rambazole
1. 201410-53-9
2. Rambazole
3. R115866
4. R-115866
5. N-(4-(2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl)phenyl)benzo[d]thiazol-2-amine
6. Talarozole (r Enantiomer)
7. Xkd9n5cj6w
8. 201410-66-4
9. N-[4-[2-ethyl-1-(1,2,4-triazol-1-yl)butyl]phenyl]-1,3-benzothiazol-2-amine
10. Chembl459505
11. (+)-n-[4-[2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine
12. 2-benzothiazolamine, N-[4-[2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl]phenyl]-
13. N-(4-((1rs)-2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl)phenyl)benzothiazol-2-amine
14. Rambazole (tn)
15. Talarozole [usan]
16. Talarozole (usan/inn)
17. Talarozole [usan:inn]
18. Unii-xkd9n5cj6w
19. 2-benzothiazolamine, N-(4-(2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl)phenyl)-
20. N-{4-[2-ethyl-1-(1,2,4-triazol-1-yl)butyl]phenyl}-1,3-benzothiazol-2-amine
21. R 115866
22. N-(4-(2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl)phenyl)-2-benzothiazolamine
23. Talarozole [inn]
24. Talarozole [who-dd]
25. Schembl721201
26. Schembl21020998
27. Gtpl11381
28. Dtxsid70942185
29. Chebi:102167
30. Bcp21218
31. Bcp28256
32. Bia41053
33. Bdbm50253810
34. Akos005067289
35. Cs-1343
36. Db13083
37. Ncgc00378894-01
38. Ncgc00378894-02
39. Hy-14531
40. Ws-02133
41. D09385
42. D85497
43. A926099
44. Q15410180
45. Rambazole; R115866; R-115866; R 115866
46. Talarozole R Enantiomer;r115866;r 115866;r-115866
47. R115866;r-115866;r 115866
48. (+/-)-n-[4-[2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazol-amine
49. (+/-)-n-[4-[2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine
50. N-{4-[2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl]phenyl}-1,3-benzothi Azol-2-amine
51. N-{4-[2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl]phenyl}-1,3-benzothiazol-2-amine
Molecular Weight | 377.5 g/mol |
---|---|
Molecular Formula | C21H23N5S |
XLogP3 | 6 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 7 |
Exact Mass | 377.16741693 g/mol |
Monoisotopic Mass | 377.16741693 g/mol |
Topological Polar Surface Area | 83.9 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 452 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Cytochrome P-450 Enzyme Inhibitors
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES. (See all compounds classified as Cytochrome P-450 Enzyme Inhibitors.)
Rambazole is a new generation all-trans retinoic acid metabolism blocking agent, highly specific against the retinoic acid 4-hydroxylase. The drug alleviates hyperproliferation and normalizes differentiation of the epidermis in animal models of psoriasis. All-trans-retinoic acid (RA) regulates epithelial differentiation and growth through activation of specific nuclear RA receptors (RARs). Rambazole acts by inhibiting the metabolic breakdown of the retinoid, increasing the biological efficacy of RA.
ABOUT THIS PAGE
A talarozole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of talarozole, including repackagers and relabelers. The FDA regulates talarozole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. talarozole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A talarozole supplier is an individual or a company that provides talarozole active pharmaceutical ingredient (API) or talarozole finished formulations upon request. The talarozole suppliers may include talarozole API manufacturers, exporters, distributors and traders.
click here to find a list of talarozole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A talarozole DMF (Drug Master File) is a document detailing the whole manufacturing process of talarozole active pharmaceutical ingredient (API) in detail. Different forms of talarozole DMFs exist exist since differing nations have different regulations, such as talarozole USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A talarozole DMF submitted to regulatory agencies in the US is known as a USDMF. talarozole USDMF includes data on talarozole's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The talarozole USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of talarozole suppliers with USDMF on PharmaCompass.
talarozole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of talarozole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right talarozole GMP manufacturer or talarozole GMP API supplier for your needs.
A talarozole CoA (Certificate of Analysis) is a formal document that attests to talarozole's compliance with talarozole specifications and serves as a tool for batch-level quality control.
talarozole CoA mostly includes findings from lab analyses of a specific batch. For each talarozole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
talarozole may be tested according to a variety of international standards, such as European Pharmacopoeia (talarozole EP), talarozole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (talarozole USP).
LOOKING FOR A SUPPLIER?